Preventive Care Practices: A Retrospective Database Study of Influenza and Pneumococcal Vaccination Among Adults with Diabetes
Main Article Content
Abstract
Background: Diabetes mellitus is a prevalent chronic disease that significantly increases the risk of complications from infections such as influenza and pneumococcal disease. Despite established recommendations for vaccination, coverage rates among adults with diabetes remain suboptimal. This study aims to analyze trends in influenza and pneumococcal vaccination rates among adults with diabetes using the United States Diabetes Surveillance System (USDSS) database.
Methods: This retrospective database study utilized data from the USDSS from 2000 to 2022, which provides comprehensive nationwide data on diabetes care. The study population included adults aged 18 and above with a documented diagnosis of diabetes. Data were extracted on demographic variables (age, sex, race/ethnicity), clinical characteristics (type of diabetes, duration of diabetes, comorbid conditions), and vaccination records. Descriptive statistics summarized demographic and clinical characteristics, while temporal trends in vaccination rates were analyzed using graphical representations.
Results: Over the past two decades, influenza vaccination rates among adults with diabetes increased from 41.4% in 2000 to 56.7% in 2019, reflecting improved awareness and healthcare practices, though slightly dipping to 54.2% in 2022. In contrast, pneumococcal vaccination rates showed more variability, starting at 29.3% in 2000, peaking at 39.4% in 2018, and declining to 30.2% in 2022, indicating challenges in maintaining high coverage. Influenza vaccination rates showed an overall increasing trend across all demographic groups: rates among Hispanic individuals increased from 32.1% in 2000 to 55.4% in 2022, non-Hispanic Whites from 43.4% to 52.7%, and non-Hispanic Blacks from 39.2% to 44.5%. Pneumococcal vaccination rates also increased but displayed more variability; Hispanic rates peaked at 33.3% in 2016, non-Hispanic Whites at 45.6% in 2019, and non-Hispanic Blacks at 41.7% in 2017. Higher educational attainment was consistently associated with higher vaccination rates for both vaccines.
Conclusions: This study highlights significant improvements in influenza and pneumococcal vaccination rates among adults with diabetes over the past two decades. However, disparities remain, particularly among racial and educational groups. Targeted strategies are necessary to address these disparities and enhance vaccination coverage, ultimately reducing the risk of severe infections in this vulnerable population.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Karagun B, Evran M, Odabas F, Akkus G, Kurtaran B, Sert M, Tetiker T. Awareness of Vaccination against Respiratory Tract Diseases, Including Pneumonia, Influenza, and COVID-19 in Patients with Diabetes Mellitus. Int J Clin Pract. 2022 Aug 10;2022:1389137. doi: 10.1155/2022/1389137. PMID: 36016827; PMCID: PMC9366267.
3. Sözen M, Karatoprak AP, Demirhan Y, Nasırlıer GÇ, Selek A, Gezer E, Çetinarslan B, Cantürk Z, Tarkun İ, Köksalan D, Azak E. Awareness of influenza and pneumococcal vaccines in diabetic patients. J Diabetes Metab Disord. 2021 May 7;20(1):757-763. doi: 10.1007/s40200-021-00812-4. PMID: 33996650; PMCID: PMC8104465.
4. Al-Sayyar A, Hulme KD, Thibaut R, Bayry J, Sheedy FJ, Short KR, Alzaid F. Respiratory Tract Infections in Diabetes - Lessons From Tuberculosis and Influenza to Guide Understanding of COVID-19 Severity. Front Endocrinol (Lausanne). 2022 Jul 26;13:919223. doi: 10.3389/fendo.2022.919223. PMID: 35957811; PMCID: PMC9363013.
5. Silverii GA, Gabutti G, Tafuri S, Sarti F, Pratesi A, Clerico A, Fornengo R, Greco C, Irace C, Sordi V, Sorice GP, Cavallo M, Ponziani MC, Mannucci E, Dicembrini I; SID-AMD-SItI Working Group on Diabetes, Vaccines. Diabetes as a risk factor for pneumococcal disease and severe related outcomes and efficacy/effectiveness of vaccination in diabetic population. Results from meta-analysis of observational studies. Acta Diabetol. 2024 Apr 29. doi: 10.1007/s00592-024-02282-5. Epub ahead of print. PMID: 38684540.
6. Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17(1):11-30. doi:10.1038/s41574-020-00435-4.
7. Noale M, Trevisan C, Maggi S, et al. The Association between Influenza and Pneumococcal Vaccinations and SARS-Cov-2 Infection: Data from the EPICOVID19 Web-Based Survey. Vaccines (Basel). 2020;8(3):471. Published 2020 Aug 23. doi:10.3390/vaccines8030471.
8. Naito T, Suzuki M, Kanazawa A, et al. Pneumococcal vaccination reduces in-hospital mortality, length of stay and medical expenditure in hospitalized elderly patients. J Infect Chemother. 2020;26(7):715-721. doi:10.1016/j.jiac.2020.03.016.
9. Alcusky MJ, Pawasauskas J. Adherence to Guidelines for Hepatitis B, Pneumococcal, and Influenza Vaccination in Patients With Diabetes. Clin Diabetes. 2015 Jul;33(3):116-22. doi: 10.2337/diaclin.33.3.116. PMID: 26203204; PMCID: PMC4503939.
10. Dallagiacoma G, Allora A, Salvati S, Cocciolo G, Capraro M, Lamberti A, Senatore S, Gentile L, Gianfredi V, Laurenzi A, Molinari C, Caretto A, Faccini M, Signorelli C, Scavini M, Odone A. Type 1 Diabetes Patients' Practice, Knowledge and Attitudes towards Influenza Immunization. Vaccines (Basel). 2021 Jun 29;9(7):707. doi: 10.3390/vaccines9070707. PMID: 34210044; PMCID: PMC8310009.
11. Mercan Baspinar M, Demirali A. The Uptake of Pneumococcal and Seasonal Influenza Vaccinations Based on Perceptions and Attitudes Toward the COVID-19 Vaccine Among Patients With Diabetes. Cureus. 2024 Mar 26;16(3):e56943. doi: 10.7759/cureus.56943. PMID: 38665703; PMCID: PMC11044189.
12. Mastrovito B, Lardon A, Dubromel A, Nave V, Beny K, Dussart C. Understanding the gap between guidelines and influenza vaccination coverage in people with diabetes: a scoping review. Front Public Health. 2024 Apr 19;12:1360556. doi: 10.3389/fpubh.2024.1360556. PMID: 38706547; PMCID: PMC11066301.
13. United States Diabetes Surveillance System (2024). Accessed: June 21, 2024. Available at: https://gis.cdc.gov/grasp/diabetes/DiabetesAtlas.html
14. 45 CFR 46 (2024). Accessed: June 21, 2024. Available at: https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html
15. Bechini A, Ninci A, Del Riccio M, Biondi I, Bianchi J, Bonanni P, Mannucci E, Monami M. Impact of Influenza Vaccination on All-Cause Mortality and Hospitalization for Pneumonia in Adults and the Elderly with Diabetes: A Meta-Analysis of Observational Studies. Vaccines (Basel). 2020 May 30;8(2):263. doi: 10.3390/vaccines8020263. PMID: 32486233; PMCID: PMC7349976.
16. Wyplosz B, Fernandes J, Sultan A, Roche N, Roubille F, Loubet P, Fougère B, Moulin B, Duhot D, Vainchtock A, Raguideau F, Lortet-Tieulent J, Blanc E, Moïsi J, Goussiaume G. Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study. Vaccine. 2022 Aug 5;40(33):4911-4921. doi: 10.1016/j.vaccine.2022.06.071. Epub 2022 Jul 7. PMID: 35811205.
17. Thewjitcharoen Y, Butadej S, Malidaeng A, Yenseung N, Nakasatien S, Lekpittaya N, Kittipoom W, Krittiyawong S, Himathongkam T. Trends in influenza and pneumococcal vaccine coverage in Thai patients with type 2 diabetes mellitus 2010-2018: Experience from a tertiary diabetes center in Bangkok. J Clin Transl Endocrinol. 2020 May 11;20:100227. doi: 10.1016/j.jcte.2020.100227. PMID: 32395432; PMCID: PMC7212954.
18. Demirci I, Haymana C, Salman S, Tasci I, Corapcioglu D, Kirik A, Yetkin İ, Altay M, Sabuncu T, Bayram F, Satman I, Sonmez A; TEMD Study Group. Rates and associates of influenza and pneumococcus vaccination in diabetes mellitus: A nationwide cross-sectional study (TEMD vaccination study). World J Diabetes. 2021 Dec 15;12(12):2107-2118. doi: 10.4239/wjd.v12.i12.2107. PMID: 35047124; PMCID: PMC8696642.
19. Hung MC, Lu PJ, Srivastav A, Cheng YJ, Williams WW. Influenza vaccination coverage among adults with diabetes, United States, 2007-08 through 2017-18 seasons. Vaccine. 2020 Sep 29;38(42):6545-6552. doi: 10.1016/j.vaccine.2020.08.008. Epub 2020 Aug 18. PMID: 32819730; PMCID: PMC9063722.
20. Alzahrani Z, Bashrahil B, Alzahrani MS, Alghamdi N, Nooh M, Alsolami H, Alghamdi AF, Alabbasi AA, Khan MA, Alzahrani AM. Trends In Hepatitis B, Influenza, And Pneumococcal Vaccination In Diabetic Patients. 2022. Doi: https://doi.org/10.21203/rs.3.rs-1427594/v1
21. Lin C, Mullen J, Smith D, Kotarba M, Kaplan SJ, Tu P. Healthcare Providers' Vaccine Perceptions, Hesitancy, and Recommendation to Patients: A Systematic Review. Vaccines (Basel). 2021 Jul 1;9(7):713. doi: 10.3390/vaccines9070713. PMID: 34358132; PMCID: PMC8310254.
22. Almasri L, Holtzclaw BJ. Assessing Vaccine Protection for Older Adults with Diabetes: A Systematic Review. West J Nurs Res. 2022 Jun;44(6):582-597. doi: 10.1177/01939459211005710. Epub 2021 Apr 13. PMID: 33845695.
23. Bell R, Imai S, Rafferty A, Little NRG, Winterbauer N, Luo H. Influenza and Pneumonia Vaccinations among North Carolina Adults with Diabetes. Am J Health Behav. 2021 Mar 1;45(2):216-225. doi: 10.5993/AJHB.45.2.2. PMID: 33888183.